Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Learn the best actions to take with your credit card points. Make informed decisions to maximize your rewards and benefits.
25,531 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Three durable businesses stand out for a buy-and-hold approach as markets adjust to AI-driven demand and steadier gro...
BNB trades near $645 as market momentum ebbs and flows with Bitcoin. Analysts flag a split scenario: a push toward $7...
Solana sits at a pivotal juncture in 2026, with traders weighing a rising wedge against thinning volume and a stubbor...
Wells Fargo and Jefferies boosted ONEOK on Wednesday, citing a structural shift in energy demand tied to Iran-related...
Tower Semiconductor is navigating a critical inflection point as it scales SiPho production and expands in Japan, wit...
Cathie Wood built a name on bold bets in disruptive tech. This piece breaks down how ARK Innovation rode dramatic swi...
The US dollar still dominates oil trades, but signals of strain are rising. Tensions in the Middle East and a push to...
Nine months after Jim Cramer touted Energy Transfer as a top dividend pick for retirees, the stock has delivered on i...
Amazon's liquidity position is tightening as it pours billions into AI infrastructure. Investors pore over cash metri...
Ferrari delivered a quarter that topped estimates, yet the stock moved lower. This piece deciphers what drove the bea...
PropLogix launches PropOptix, a sales outreach platform that uses real-time market signals to connect title firms wit...